ELRANATAMAB

Clinical trials for ELRANATAMAB explained in plain language.

Never miss a new study

Get alerted when new ELRANATAMAB trials appear

Sign up with your email to follow new studies for ELRANATAMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Radiation boosts cancer drug in Tough-to-Treat myeloma

Disease control Recruiting now

This study tests whether adding low-dose radiation to the drug elranatamab can better kill cancer cells in people with multiple myeloma that has come back or not responded to treatment and has spread outside the bone. About 34 adults will receive the combination. The goal is to s…

Matched conditions: ELRANATAMAB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:07 UTC

ELRANATAMAB

Get alerted when new ELRANATAMAB trials appear

Radiation boosts cancer drug in Tough-to-Treat myeloma